Monitor for selling stockholder activity post-effectiveness; the registration covers ~23.7% of outstanding shares, which could create near-term overhang. Watch for any subsequent secondary offerings or block trades.
Executive Summary
MapLight Therapeutics filed Amendment No. 1 to its S-1 registration statement, solely to correct the number of shares outstanding as of September 1, 2026. The filing registers up to 13,181,055 shares of common stock for resale by selling stockholders, all issued in a $150.0 million private placement that closed on August 14, 2026. The company will not receive any proceeds from this resale offering.
Key Facts
- Amendment No. 1 to S-1 corrects share count only; no additional securities registered.
- Registers up to 13,181,055 shares for resale by selling stockholders from an August 2026 private placement.
- Private placement closed August 14, 2026, raising gross proceeds of approximately $150.0 million.
- Company will not receive any proceeds from this resale offering.
- Stock closed at $11.32 per share on September 17, 2026.
Financial Impact
No proceeds to company; selling stockholders may sell up to 13,181,055 shares at market prices.
Risk Factors
- Potential overhang from up to 13.2 million shares registered for resale.
- Clinical-stage biotech with no approved products and history of operating losses.
- Requires substantial additional financing to fund development programs.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001193125-26-395559 |
| Document: d546679dex231.htm | 0001193125-26-395559 |
| Document: 0001193125-26-395559-index-headers.html | 0001193125-26-395559 |
| Document: 0001193125-26-395559-index.html | 0001193125-26-395559 |
| Document: 0001193125-26-395559.txt | 0001193125-26-395559 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers